Globally acknowledged hashish model Dosist will debut in New York and Florida in addition to worldwide markets, together with Canada, following its acquisition by Los Angeles-based Closing Bell Holdings Worldwide Ltd.

Why It Issues

Closing Bell’s acquisition of Dosist permits the corporate to fast-track client entry to the trusted model’s focused formulation, proprietary award-winning dose-controlled gadgets, and fast-acting gummies into markets which have lengthy sought its modern {hardware} and platform of precision dosing.

“With this strategic acquisition, we are poised to advance the founding mission of dosist – established in 2016 – to solidify our status as the premier global cannabis brand, synonymous with trust,” Jason DeLand, the founding father of dosist stated. “As we embrace the forthcoming phases of growth, I’m devoted to upholding the pillars of simplicity, design and innovation that outline our model.”

Final Bell CEO Robert Meyer seconded DeLand.

“We’re honored to have the opportunity to build upon the foundation this brand has built and will aggressively scale its footprint, bringing Dosist’s products to new geographies, and introducing a new vision for the brand that includes an exciting line expansion that marries its pioneering, patented technology with the cannabis products core consumers want most,” Meyer said.

14TH Round, Final Bell’s subsidiary, has been the exclusive hardware and packaging manufacturer for Dosist since its founding. The brand has also worked with Final Bell for more than three years for co-manufacturing in California.

What Is Dosist?

Founded in 2016, Dosist products include special formulations that target specific need states – “calm,” “bliss,” “sleep” and “arouse.”

The Dosist cannabis delivery system caters to consumers seeking natural plant-based therapies that are consistent, effective and predictable.

Dosist’s vape technology’s recent press coverage includes:

Featured on Time magazine’s “25 Best Inventions” list in 2016.
Recognized by Fast Company magazine as one of the health sector’s “Most Innovative Companies” in 2018.
Featured on LinkedIn’s “10 Hottest U.S. Startups to Work For” list in 2019.

Missed the first wave of cannabis investments? Don’t make that mistake again.

Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.

Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!

Just this year, the PotProfits portfolio has seen smoking-hot gains like:

47.10% with $GTBIF
40.23% with $TCNNF
21.50% with $VFF

But here’s the kicker: Michael is about to release his next potential winners, and he’s chomping at the bit to share these ticker symbols with you ASAP.

Don’t miss out on the inexperienced rush!